ASX Growth Companies With Insider Ownership Up To 38%

In This Article:

In recent trading, the ASX200 has experienced a slight decline, closing down 0.3%, with most sectors finishing in the red despite a rise in consumer spending and anticipation surrounding the federal budget announcement. This backdrop of fluctuating market conditions and keen investor interest in sectors like critical minerals and housing highlights the importance of considering stable growth opportunities, such as companies with high insider ownership which may offer aligned interests between shareholders and management.

Top 10 Growth Companies With High Insider Ownership In Australia

Name

Insider Ownership

Earnings Growth

Hartshead Resources (ASX:HHR)

13.9%

86.3%

Cettire (ASX:CTT)

28.7%

29.9%

Gratifii (ASX:GTI)

15.6%

112.4%

Acrux (ASX:ACR)

14.6%

115.3%

Doctor Care Anywhere Group (ASX:DOC)

28.4%

96.4%

Hillgrove Resources (ASX:HGO)

10.4%

45.4%

Alpha HPA (ASX:A4N)

28.3%

95.9%

Liontown Resources (ASX:LTR)

16.4%

64.3%

Argosy Minerals (ASX:AGY)

15.1%

129.6%

Chrysos (ASX:C79)

22.2%

57.5%

Click here to see the full list of 90 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Emerald Resources

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Emerald Resources NL is a company focused on the exploration and development of mineral reserves in Cambodia and Australia, with a market capitalization of approximately A$2.34 billion.

Operations: The company generates revenue primarily from mine operations, totaling approximately A$339.32 million.

Insider Ownership: 18.6%

Emerald Resources, trading at a significant discount to its estimated fair value, shows robust growth prospects with earnings and revenue forecasted to outpace the Australian market. Despite a low projected return on equity in three years and recent shareholder dilution, the company has demonstrated strong past earnings growth of 53.4% year-over-year. Recent financials confirm this trend, with substantial increases in sales and net income as reported in their latest half-year results.

ASX:EMR Earnings and Revenue Growth as at May 2024
ASX:EMR Earnings and Revenue Growth as at May 2024

Nanosonics

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Nanosonics Limited is an infection prevention company operating both in Australia and internationally, with a market capitalization of approximately A$902.88 million.

Operations: The company generates its revenue primarily from the healthcare equipment segment, totaling approximately A$164.07 million.

Insider Ownership: 15.2%